Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Isaac Zwicker, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21CA231000 (KENNEDY, DANIEL ROBERT) Sep 1, 2019 - Aug 31, 2021
    Response to PQ12 - Using thiol isomerase inhibitors to diminish cancer induced thrombosis
    Role: Co-Principal Investigator
  2. U01HL143365 (ZWICKER, JEFFREY) Aug 1, 2018 - Jul 31, 2023
    Biomarkers and mechanisms in cancer associated thrombosis
    Role: Principal Investigator
  3. R34HL135226 (ZWICKER, JEFFREY) Jul 5, 2017 - Jun 30, 2020
    Thromboprophylaxis with rosuvastatin following surgery for ovarian cancer
    Role: Principal Investigator
  4. R34HL127156 (ZWICKER, JEFFREY) Feb 10, 2016 - Jan 31, 2019
    Risk-adapted thromboprophylaxis of hospitalized cancer patients
    Role: Co-Principal Investigator
  5. U54HL112302 (FURIE, BRUCE) Sep 1, 2012 - Apr 30, 2017
    Protein disulfide isomerases: A new class of antithrombotic targets
    Role: Co-Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Wang TF, Zwicker JI, Ay C, Pabinger I, Falanga A, Antic D, Noble S, Khorana AA, Carrier M, Meyer G. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Oct; 17(10):1772-1778. PMID: 31353841.
  2. Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, Hamdan A, Antun AG, Metjian A, Sadler JE. Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood. 2019 Sep 26; 134(13):1106-1109. PMID: 31331919.
  3. Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 2019 02 21; 4(4). PMID: 30652973.
    Citations:    Fields:    
  4. Mantia C, Zwicker JI. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors. Cancer Treat Res. 2019; 179:179-189. PMID: 31317488.
  5. Carney BJ, Uhlmann EJ, Puligandla M, Mantia C, Weber GM, Neuberg DS, Zwicker JI. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. J Thromb Haemost. 2019 01; 17(1):72-76. PMID: 30450803.
    Citations:    Fields:    
  6. Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, Büller HR, Raskob GE. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug; 118(8):1439-1449. PMID: 30060256.
    Citations:    Fields:    
  7. Samuelson Bannow BR, Lee AYY, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M. Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Res Pract Thromb Haemost. 2018 Oct; 2(4):664-669. PMID: 30349884.
  8. Samuelson Bannow BT, Lee A, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost. 2018 06; 16(6):1246-1249. PMID: 29737593.
    Citations: 1     Fields:    
  9. Stopa JD, Zwicker JI. The intersection of protein disulfide isomerase and cancer associated thrombosis. Thromb Res. 2018 04; 164 Suppl 1:S130-S135. PMID: 29703471.
    Citations:    Fields:    Translation:Humans
  10. Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med. 2018 Feb 15; 378(7):615-624. PMID: 29231094.
    Citations: 24     Fields:    Translation:Humans
  11. Mantia C, Uhlmann EJ, Puligandla M, Weber GM, Neuberg D, Zwicker JI. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. 2017 06 22; 129(25):3379-3385. PMID: 28468796.
    Citations: 6     Fields:    Translation:Humans
  12. Zwicker JI. Risking thromboembolism: podoplanin and glioma. Blood. 2017 03 30; 129(13):1742-1743. PMID: 28360357.
    Citations: 1     Fields:    Translation:Humans
  13. Stopa JD, Neuberg D, Puligandla M, Furie B, Flaumenhaft R, Zwicker JI. Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. JCI Insight. 2017 01 12; 2(1):e89373. PMID: 28097231.
    Citations: 6     Fields:    
  14. Rosenblatt J, Stone RM, Uhl L, Neuberg D, Joyce R, Levine JD, Arnason J, McMasters M, Luptakova K, Jain S, Zwicker JI, Hamdan A, Boussiotis V, Steensma DP, DeAngelo DJ, Galinsky I, Dutt PS, Logan E, Bryant MP, Stroopinsky D, Werner L, Palmer K, Coll M, Washington A, Cole L, Kufe D, Avigan D. Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions. Sci Transl Med. 2016 12 07; 8(368):368ra171. PMID: 27928025.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  15. Zwicker JI. Scattering the spotlight on microparticles. J Thromb Haemost. 2017 01; 15(1):185-186. PMID: 27778450.
    Citations:    Fields:    Translation:HumansCells
  16. Zwicker JI, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation: reply. J Thromb Haemost. 2016 10; 14(10):2082. PMID: 27477626.
    Citations:    Fields:    Translation:Humans
  17. Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost. 2016 09; 14(9):1736-40. PMID: 27306689.
    Citations: 5     Fields:    Translation:Humans
  18. Weinstock MJ, Uhlmann EJ, Zwicker JI. Intracranial hemorrhage in cancer patients treated with anticoagulation. Thromb Res. 2016 Apr; 140 Suppl 1:S60-5. PMID: 27067980.
    Citations: 3     Fields:    Translation:Humans
  19. Galinski CN, Zwicker JI, Kennedy DR. Revisiting the mechanistic basis of the French Paradox: Red wine inhibits the activity of protein disulfide isomerase in vitro. Thromb Res. 2016 Jan; 137:169-173. PMID: 26585763.
    Citations:    Fields:    Translation:AnimalsCells
  20. Donato J, Campigotto F, Uhlmann EJ, Coletti E, Neuberg D, Weber GM, Zwicker JI. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. Blood. 2015 Jul 23; 126(4):494-9. PMID: 25987658.
    Citations: 11     Fields:    Translation:Humans
  21. Arnason JE, Luptakova K, Rosenblatt J, Tzachanis D, Avigan D, Zwicker JI, Levine J, Kim M, Parker JA, Grant B, Joyce RM. Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant. Acta Haematol. 2015; 133(4):347-53. PMID: 25677780.
    Citations: 1     Fields:    Translation:Humans
  22. Khorana AA, Zwicker JI, Connolly GC, Pabinger I. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: reply. J Thromb Haemost. 2015 Feb; 13(2):325-6. PMID: 25408162.
    Citations:    Fields:    Translation:Humans
  23. Shields K, Cumming M, Rios J, Wong MT, Zwicker JI, Stramer SL, Alonso CD. Transfusion-associated Anaplasma phagocytophilum infection in a pregnant patient with thalassemia trait: a case report. Transfusion. 2015 Apr; 55(4):719-25. PMID: 25385549.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  24. Carrier M, Khorana AA, Zwicker JI. The reply. Am J Med. 2014 Oct; 127(10):e13. PMID: 25311068.
    Citations:    Fields:    Translation:HumansPHPublic Health
  25. Khorana AA, Otten HM, Zwicker JI, Connolly GC, Bancel DF, Pabinger I. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014 Nov; 12(11):1928-31. PMID: 25208230.
    Citations: 8     Fields:    Translation:Humans
  26. Zwicker JI, Bauer KA. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol. 2014 Nov 10; 32(32):3596-9. PMID: 25267753.
    Citations:    Fields:    Translation:Humans
  27. Flaumenhaft R, Furie B, Zwicker JI. Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease. Arterioscler Thromb Vasc Biol. 2015 Jan; 35(1):16-23. PMID: 25104801.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  28. Carrier M, Khorana AA, Zwicker JI. The reply. Am J Med. 2014 Jul; 127(7):e35. PMID: 24970611.
    Citations:    Fields:    Translation:HumansPHPublic Health
  29. Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA. Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study. J Clin Oncol. 2014 Jun 10; 32(17):1792-6. PMID: 24799475.
    Citations: 3     Fields:    Translation:Humans
  30. Zwicker JI, Connolly G, Carrier M, Kamphuisen PW, Lee AY. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014 May; 12(5):796-800. PMID: 24548519.
    Citations: 6     Fields:    Translation:Humans
  31. Zwicker JI. Unconventional approaches to the prevention of cancer associated thrombosis. Thromb Res. 2014 May; 133 Suppl 2:S44-8. PMID: 24862145.
    Citations: 2     Fields:    Translation:Humans
  32. Carrier M, Khorana AA, Zwicker JI, Noble S, Lee AY. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a reply to a rebuttal. J Thromb Haemost. 2014 Jan; 12(1):116-7. PMID: 24406069.
    Citations: 3     Fields:    Translation:Humans
  33. Carrier M, Khorana AA, Moretto P, Le Gal G, Karp R, Zwicker JI. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med. 2014 Jan; 127(1):82-6.e1. PMID: 24384102.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  34. Carrier M, Khorana AA, Zwicker J, Noble S, Lee AY. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2013 Sep; 11(9):1760-5. PMID: 23809334.
    Citations: 21     Fields:    Translation:Humans
  35. Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol. 2013 Feb; 160(4):530-7. PMID: 23240761.
    Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
  36. Carrier M, Khorana AA, Zwicker JI, Lyman GH, Le Gal G, Lee AY. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis. J Thromb Haemost. 2012 Dec; 10(12):2599-601. PMID: 23362524.
    Citations: 3     Fields:    Translation:Humans
  37. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012 Aug 07; 345:e4944. PMID: 22872710.
    Citations: 16     Fields:    Translation:Humans
  38. Campigotto F, Neuberg D, Zwicker JI. Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier. J Thromb Haemost. 2012 Jul; 10(7):1449-51. PMID: 22554355.
    Citations: 8     Fields:    Translation:Humans
  39. Khorana AA, Spyropoulos AC, Zwicker J, Lyman GH, Francis CW. Preventing VTE in Outpatients With Cancer. Chest. 2012 Jul; 142(1):265-266. PMID: 22796860.
    Citations: 1     Fields:    Translation:Humans
  40. Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D. Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunol Immunother. 2013 Jan; 62(1):39-49. PMID: 22733396.
    Citations: 39     Fields:    Translation:HumansCells
  41. Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA. Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res. 2012 Sep; 130(3):361-8. PMID: 22542362.
    Citations: 17     Fields:    Translation:HumansCells
  42. Campigotto F, Neuberg D, Zwicker JI. Accounting for death as a competing risk in cancer-associated thrombosis studies. Thromb Res. 2012 Apr; 129 Suppl 1:S85-7. PMID: 22682141.
    Citations: 2     Fields:    Translation:Humans
  43. Theisen-Toupal J, Rosenthal ES, Kelly E, Zwicker JI, Akuthota P, Roberts DH. Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide. Respir Care. 2012 Jul; 57(7):1175-7. PMID: 22369887.
    Citations: 1     Fields:    Translation:Humans
  44. Zwicker JI, Lacroix R, Dignat-George F, Furie BC, Furie B. Measurement of platelet microparticles. Methods Mol Biol. 2012; 788:127-39. PMID: 22130705.
    Citations: 7     Fields:    Translation:HumansCells
  45. Zwicker JI, Trenor CC, Furie BC, Furie B. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol. 2011 Apr; 31(4):728-33. PMID: 21252066.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  46. Zwicker JI. Impedance-based flow cytometry for the measurement of microparticles. Semin Thromb Hemost. 2010 Nov; 36(8):819-23. PMID: 21049382.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  47. Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res. 2010 Apr; 125 Suppl 2:S89-91. PMID: 20434015.
    Citations: 18     Fields:    Translation:HumansCells
  48. Mantha S, Bauer KA, Zwicker JI. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost. 2010 Feb; 8(2):263-8. PMID: 19912516.
    Citations: 4     Fields:    Translation:Humans
  49. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009 Nov 15; 15(22):6830-40. PMID: 19861441.
    Citations: 101     Fields:    Translation:Humans
  50. Zwicker JI. Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost. 2008 Mar; 34(2):195-8. PMID: 18645925.
    Citations: 8     Fields:    Translation:HumansCells
  51. Freedman RA, Bauer KA, Neuberg DS, Zwicker JI. Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):55-9. PMID: 18180616.
    Citations: 1     Fields:    Translation:Humans
  52. Zwicker JI, Furie BC, Furie B. Cancer-associated thrombosis. Crit Rev Oncol Hematol. 2007 May; 62(2):126-36. PMID: 17293122.
    Citations: 32     Fields:    Translation:HumansAnimals
  53. Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, Mannucci P. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood. 2006 Aug 15; 108(4):1280-3. PMID: 16684956.
    Citations: 17     Fields:    Translation:HumansCells
  54. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004 Dec; 2(12):2133-7. PMID: 15613017.
    Citations: 34     Fields:    Translation:Humans
  55. Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol. 2004 Oct; 51(4):660-2. PMID: 15389210.
    Citations: 12     Fields:    Translation:Humans
  56. Näär AM, Beaurang PA, Robinson KM, Oliner JD, Avizonis D, Scheek S, Zwicker J, Kadonaga JT, Tjian R. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev. 1998 Oct 01; 12(19):3020-31. PMID: 9765204.
    Citations: 60     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zwicker's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (223)
Co-Authors (40)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.